{"id":338435,"date":"2026-08-14T09:42:11","date_gmt":"2026-08-14T09:42:11","guid":{"rendered":"https:\/\/www.europesays.com\/se\/338435\/"},"modified":"2026-08-14T09:42:11","modified_gmt":"2026-08-14T09:42:11","slug":"valneva-rusar-efter-ema-besked-om-granskning-av-borreliavaccin","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/338435\/","title":{"rendered":"Valneva rusar efter EMA-besked om granskning av borreliavaccin"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Franska vaccinspecialisten Valneva steg med \u00f6ver 20 procent p\u00e5 fredagen efter att den europeiska l\u00e4kemedelsmyndigheten EMA validerat bolagets och Pfizers ans\u00f6kan om marknadsgodk\u00e4nnande f\u00f6r vaccinkandidaten PF-07307405 mot borrelia. D\u00e4rmed inleds EMA:s formella granskning.\n <\/p>\n<p>Vaccinet visade \u00f6ver 70 procents effektivitet i en fas 3-studie med 9 437 deltagare.\n <\/p>\n<p>Stifel ser EMA-beskedet som en viktig riskminskning och r\u00e4knar med ett godk\u00e4nnande under tredje kvartalet 2027, skriver Bloomberg.\n <\/p>\n<p>TD Cowen uppskattar den globala toppf\u00f6rs\u00e4ljningen till cirka 3,1 miljarder euro 2035, motsvarande omkring 590 miljoner euro i royaltyint\u00e4kter f\u00f6r Valneva.<br \/>\n <br class=\"col-start-2\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Merima Tikvesa<br \/>\n <br class=\"col-start-2\"\/><br \/>\n Nyhetsbyr\u00e5n Finwire<\/p>\n","protected":false},"excerpt":{"rendered":"Franska vaccinspecialisten Valneva steg med \u00f6ver 20 procent p\u00e5 fredagen efter att den europeiska l\u00e4kemedelsmyndigheten EMA validerat bolagets&hellip;\n","protected":false},"author":2,"featured_media":338436,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[69],"tags":[113,112,6458,34,31,33,32,30,37329,37330],"class_list":["post-338435","post","type-post","status-publish","format-standard","has-post-thumbnail","category-halsa","tag-halsa","tag-health","tag-pfizer","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-valneva","tag-valneva-se"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117093213285305162","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/338435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=338435"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/338435\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/338436"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=338435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=338435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=338435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}